Bruker (BRKR) Income from Continuing Operations (2010 - 2026)
Bruker (BRKR) posted Income from Continuing Operations of 19400000.0 for Q1 2026, up 104.69% on a QoQ basis from 413900000.0 in Q4 2025, and up 18.29% year-over-year from 16400000.0 in Q1 2025.
Bruker (BRKR) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Bruker's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 19400000.0 for Q1 2026.
- Quarterly Income from Continuing Operations rose 18.29% year-over-year to 19400000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 323700000.0 (up 3.63% YoY) and the FY2025 annual result came in at 451600000.0, down 68.07% from the prior year.
- Income from Continuing Operations was 19400000.0 for Q1 2026 at Bruker, up from 413900000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 177400000.0 in Q4 2023 and bottomed at 413900000.0 in Q4 2025.
- A 5-year average of 35435294.12 and a median of 30000000.0 in 2022 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations sank 672.34% — and 2023, when it jumped 152.08%.
- Bruker's Income from Continuing Operations stood at 340600000.0 in 2022, then soared by 152.08% to 177400000.0 in 2023, then slumped by 307.89% to 368800000.0 in 2024, then dropped by 12.23% to 413900000.0 in 2025, then jumped by 104.69% to 19400000.0 in 2026.
- Business Quant data shows BRKR's Income from Continuing Operations at 19400000.0 in Q1 2026, 413900000.0 in Q4 2025, and 73700000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - | - |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn | 273.95 Mn |
| 10 | Bruker | 9.25 Bn | 9.25 Bn | 379.80 Mn | 19.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.40 Mn |
| Dec 31, 2025 | -413.90 Mn |
| Sep 30, 2025 | 73.70 Mn |
| Jun 30, 2025 | -2.90 Mn |
| Mar 31, 2025 | 16.40 Mn |
| Dec 31, 2024 | -368.80 Mn |
| Sep 30, 2024 | 40.50 Mn |
| Jun 30, 2024 | -24.00 Mn |
| Mar 31, 2024 | -72.10 Mn |
| Dec 31, 2023 | 177.40 Mn |
| Sep 30, 2023 | 58.30 Mn |
| Jun 30, 2023 | 38.30 Mn |
| Mar 31, 2023 | 47.60 Mn |
| Dec 31, 2022 | -340.60 Mn |
| Sep 30, 2022 | 88.10 Mn |
| Jun 30, 2022 | 30.00 Mn |
| Mar 31, 2022 | 30.20 Mn |
| Dec 31, 2021 | -44.10 Mn |
| Sep 30, 2021 | 88.10 Mn |
| Jun 30, 2021 | -80.00 Mn |